0001209191-23-056514.txt : 20231122
0001209191-23-056514.hdr.sgml : 20231122
20231122171801
ACCESSION NUMBER: 0001209191-23-056514
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231121
FILED AS OF DATE: 20231122
DATE AS OF CHANGE: 20231122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Roemer Alan S.
CENTRAL INDEX KEY: 0001643070
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40045
FILM NUMBER: 231434447
MAIL ADDRESS:
STREET 1: C/O AXOVANT SCIENCES, INC.
STREET 2: 1441 BROADWAY, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NexImmune, Inc.
CENTRAL INDEX KEY: 0001538210
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9119 GAITHER ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 301-825-9810
MAIL ADDRESS:
STREET 1: 9119 GAITHER ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-21
0
0001538210
NexImmune, Inc.
NEXI
0001643070
Roemer Alan S.
C/O NEXIMMUNE, INC.
9119 GAITHER ROAD
GAITHERSBURG
MD
20877
1
0
0
0
0
Common Stock
2023-11-21
4
S
0
3833
2.1621
D
3992
D
Common Stock
2023-11-22
4
S
0
3992
1.9434
D
0
D
The price reflects the average selling price of the common stock sold. These shares were sold in multiple transactions at prices ranging from $2.05 to $2.39 per common stock. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of common stock sold at each price.
The price reflects the average selling price of the common stock sold. These shares were sold in multiple transactions at prices ranging from $1.91 to $2.05 per common stock. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of common stock sold at each price.
/s/John Rudy, attorney-in-fact
2023-11-22